-+ 0.00%
-+ 0.00%
-+ 0.00%

BRIEF-Zai Lab Announces Global Clinical Trial Collaboration And Supply Agreement To Evaluate Novel Dll3 Adc, Zocilurtatug Pelitecan, In Combination With A Bispecific T-Cell Engager Therapy

Reuters·04/01/2026 12:34:49

Please log in to view news